LAS VEGAS — Results presented at the American Academy of Orthopaedic Surgeons Annual Meeting showed patients who were prescribed anabolic bone-forming medications were not at increased risk for developing primary bone neoplasm.
“Further prospective studies with long-term monitoring data may demonstrate the benefit of these medications with ongoing monitoring for malignancy,” Daniel J. Alsoof, BS, MBBS, a research fellow in the department of orthopedics at Brown University, said in his presentation here.
Use the PearlDiver Mariner data between 2010-2020, Alsoof
